Advertisement

The Neuropsychology of Pediatric Epilepsy and Antiepileptic Drugs

  • Thomas L. Bennett
  • Maile R. Ho
Part of the Critical Issues in Neuropsychology book series (CINP)

Abstract

Epilepsy is a nervous system disturbance that abruptly interferes with ongoing behavior, perception, movement, consciousness, or other brain functions. Individual attacks are called seizures, and when the problem is consistent it is called either a seizure disorder or epilepsy. Seizures are relatively common among infants, children, and adolescents with Hauser (1994) estimating 30,000 newly diagnosed cases of epilepsy in children in the United States for 1990 alone. Probably 8 of every 1000 children experience some sort of seizure activity, even if it is only a single occurrence of a febrile seizure (Lechtenberg, 1984). Occasionally, a seizure disorder will disappear as a child matures, but in a majority of cases, epilepsy persists into adulthood, and in 80% of adults with epilepsy, this condition developed when they were children. The purpose of this chapter is to describe the neuropsychology of pediatric epilepsy, and the emphasis will be to discuss the emotional/behavioral and cognitive concomitants of epilepsy and antiepileptic drugs (AEDs). We use the term concomitants to underscore the fact that epilepsy is a complex phenomenon, and the behavioral and cognitive events associated with it are the product of a complex interaction among neurological, medication, and psychosocial variables (Hermann & Whitman, 1986).

Keywords

Temporal Lobe Antiepileptic Drug Temporallobe Epilepsy Partial Seizure Seizure Frequency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abou-Khalil, B., Shellenberger, M. K., & Anhut, H. (1992). Two open-label, multicenter studies of the safety and efficacy of gabapentin in patients with refractory epilepsy. Epilepsia, 33, 77.Google Scholar
  2. American Academy of Pediatrics. (1985). Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics, 76 (4), 644–647.Google Scholar
  3. Andrewes, D. G., Tomlinson, L., Elwes, R. D., & Reynolds, E. H. (1984). The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy. Acta Neurologica Scandinavica, 69 (Suppl. 99), 23–30.CrossRefGoogle Scholar
  4. Arieff, A. J., & Yacorzynski, G. K. (1942). Deterioration of patients with organic epilepsy. Journal of Nervous and Mental Disease, 96, 49–55.Google Scholar
  5. Austin, J. K., Smith, M. S., Risinger, M. W., & McNelis, A. M. (1994). Childhood epilepsy and asthma: Comparison of quality of life. Epilepsia, 35 (3), 608–615.PubMedCrossRefGoogle Scholar
  6. Bagley, C. (1971). The social psychology of the child with epilepsy. London: Routledge and Kegan Paul.Google Scholar
  7. Barnes, S. E., & Bower, B. D. (1975). Sodium valproate in the treatment of intractable childhood epilepsy. Developmental Medicine and Child Neurology, 17, 175–181.PubMedCrossRefGoogle Scholar
  8. Batzel, L. W., Dodrill, C. B., Dubinsky, B. L., Ziegler, R. G., Connolly, J. E., Freeman, R. D., Farwell, J. R., & Vining, E. P. G. (1991). An objective method for the assessment of psychosocial problems in adolescents with epilepsy. Epilepsia, 32(2), 202–211.Google Scholar
  9. Bauer, G., Bechinger, D., Castell, M., Deisenhammer, E., & Egli, M. (1989). Gabapentin in the treatment of drug-resistant epileptic patients. Advances in Epileptology, 17, 219–221.Google Scholar
  10. Bear, D. M. (1979). Temporal lobe epilepsy: A syndrome of sensory-limbic hyperconnection. Cortex, 15, 357–384.PubMedGoogle Scholar
  11. Bear, D. M., & Fedio, P. (1977). Quantitative analysis of interictal behavior in temporal lobe epilepsy. Archives of Neurology, 34, 454–467.PubMedCrossRefGoogle Scholar
  12. Bear, D. M., Freeman, R., & Greenberg, M. (1984). Behavioral alterations in patients with temporal lobe epilepsy. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 197–227 ). Washington, DC: American Psychiatric Press.Google Scholar
  13. Bellur, S., & Hermann, B. P. (1984). Emotional and cognitive effects of anticonvulsant medications. The International Journal of Clinical Neuropsychology, 6, 21–23.Google Scholar
  14. Ben-Menachem, E., Persson, L. I., Schechter, P. J., Haegele, K. D., Huebert, N., Hardenberg, J., Dahlgren, L., and Mum-ford, J. P. (1989). The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. British Journal of Clinical Pharmacy, 27, 79S - 85S.Google Scholar
  15. Bennett, T. L. (1987). Neuropsychological aspects of complex partial seizures: Diagnostic and treatment issues. The International Journal of Clinical Neuropsychology, 9 (1), 37–45.Google Scholar
  16. Bennett, T. L. (1988). Use of the Halstead-Reitan Neuropsychological Test Battery in the assessment of head injury. Cognitive Rehabilitation, May/June, 18–24.Google Scholar
  17. Betts, T., Goodwin, G., Withers, R. M.,&Yuen, A. W. C. (1991). Human safety of lamotrigine. Human safety of lamotrigine. Epilepsia, 32 (Suppl. 2), S17 - S19.PubMedCrossRefGoogle Scholar
  18. Beyers, V. L. (1993). Novel antiepileptic drugs: Nursing implications. Journal of Neuroscience Nursing, 25 (6), 375–379.CrossRefGoogle Scholar
  19. Blumer, D., and Benson, D. F. (1982). Psychiatric manifestations of epilepsy. In D. F. Benson and D. Blumer (Eds.), Psychiatric aspects of neurological disease (Vol. 2, pp. 25–48 ). New York: Grune and Stratton.Google Scholar
  20. Browne, S. W., and Reynolds, E. H. (1981). Cognitive impairment in epileptic patients. In E. H. Reynolds and M. R. Trimble (Eds.), Epilepsy and psychiatry (pp. 147–164 ). London: Churchill Livingstone.Google Scholar
  21. Browne, T. (1993). Long-term efficacy and toxicity of gabapentin. Neurology, 43, A307.Google Scholar
  22. Browne, T. R., Dreifuss, F. E., Dyken, P. R., Goode, D. J., Penry, J. K., Porter, R. J., White, B. J., and White, P. T. (1975). Ethosuccimide in the treatment of absences (petit mal) seizures. Neurology, 25, 515–525.Google Scholar
  23. Browne, T. R., Mattson, P. H., Penry, J. K., Smith, D. B., Treiman, D. M., Wilder, B. J., Ben-Menachem, E., Miketta, R. M., Sherry, K. M., and Szabo, G. K. (1989). A multicentre study of vigabatrin for drug-resistant epilepsy. British Journal of Clinical Pharmacy, 27, 95S - 100S.CrossRefGoogle Scholar
  24. Bruhm, P., and Parsons, O. A. (1977). Reaction time variability in epileptic and brain-damaged patients. Cortex, 13, 373–384.Google Scholar
  25. Committee on Drugs. (1985). Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics, 76, 644–647.Google Scholar
  26. Corbett, J. A., Trimble, M. R., and Nichol, T. C. (1985). Behavioral and cognitive impairments in children with epilepsy: The long-term effects of anticonvulsant therapy. Journal of the American Academy of Child Psychiatry, 24, 17–23.Google Scholar
  27. Crawford, R, Ghadiel, E., Lane, R., Blumhardt, L., and Chadwick, D. (1987). Gabapentin as an antiepileptic drug in man. Journal of Neurology, Neurosurgery, and Psychiatry, 49, 1251–1257.Google Scholar
  28. Dalby, M. A. (1975). Behavioral effects of carbamazepine. In J. K. Penry and D. D. Daly (Eds.), Advances in Neurology (Vol. 11, pp. 331–343 ). New York: Raven Press.Google Scholar
  29. Davidson, D. L. W. (1983). A review of the side effects of sodium valproate. British Journal of Clinical Practice, 27 (Suppl.), 79–85.Google Scholar
  30. Dean, J. C. (1993). Valproate. In E. Wyllie (Ed.), The treatment of epilepsy: Principles and practices (pp. 915–923 ). Philadelphia: Lea and Febiger.Google Scholar
  31. Delaney, R. C., Rosen, A. J., Mattson, R. H., and Novelly, R. A. (1980). Memory function in focal epilepsy: A comparison of non-surgical, unilateral temporal lobe and frontal lobe samples. Cortex, 16, 103–117.PubMedGoogle Scholar
  32. Dewhurst, K. (1980). Thomas Willis’ Oxford Lectures. Oxford: Sanford.Google Scholar
  33. Dikmen, S., and Matthews, C. G. (1977). Effect of major motor seizure frequency upon cognitive-intellectual function in adults. Epilepsia, 18, 21–29.PubMedCrossRefGoogle Scholar
  34. Dikmen, S., Matthews, C. G., and Harley, J. P. (1977). Effect of early versus late onset of major motor epilepsy upon cognitive-intellectual function in adults. Epilepsia, 16, 73–81.CrossRefGoogle Scholar
  35. Dikmen, S., and Reitan, R. (1978). Neuropsychological perfor-mance in posttraumatic epilepsy. Epilepsia, 18, 31–36.Google Scholar
  36. Dodrill, C. B. (1978). A neuropsychological battery for epilepsy. Epilepsia, 19, 611–623.PubMedCrossRefGoogle Scholar
  37. Dodrill, C. B. (1981). Neuropsychology of epilepsy. In S. B. Filskov and T. J. Boll (Eds.), Handbook of clinical neuropsychology (pp. 366–395 ). New York: Wiley.Google Scholar
  38. Dodrill, C. B., and Troupin, A. S. (1977). Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin. Neurology, 27, 1023–1028.PubMedCrossRefGoogle Scholar
  39. Dodrill, C. B., and Troupin, A. S. (1991). Neuropsychological effects of carbamazepine and phenytoin: A reanalysis. Neurology, 41, 141–143.PubMedCrossRefGoogle Scholar
  40. Dodrill, C. B., Wilensky, A. J., Ojeman, L., Temkin, N., and Shellenberger, K. (1992). Neuropsychological, mood, and psychosocial effects of gabapentin. Epilepsia, 33, 117–118.CrossRefGoogle Scholar
  41. Dodson, W. E., and Pellock, J. M. (Eds.). (1993). Pediatric epilepsy: Diagnosis and therapy. New York: Demos.Google Scholar
  42. Dulac, O., Withers, R. M., and Yuen, A. W. C. (1991). Add-on lamotrigine in pediatric patients with resistant epilepsy (Abstract). Epilepsia, 32 (Suppl. 3), 10.Google Scholar
  43. Duncan, J. S., Shorvon, S. D., and Trimble, M. R. (1990). Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function. Epilepsia, 31(5), 584–591.Google Scholar
  44. Farwell, J. R., Dodrill, C. B., and Batzel, L. W. (1985). Neuropsychological abilities in children with epilepsy. Epilepsia, 26(5),395–400.Google Scholar
  45. Farwell, J. R., Lee, Y. J., Hinz, D. G., Sulzbacher, S. I., Ellenberg, J. H., and Nelson, K. B. (1990). Phenobarbital for febrile seizures: Effects on intelligence and on seizure recurrence. New England Journal of Medicine, 322, 364–369.Google Scholar
  46. Fedio, P., and Mirsky, A. F. (1969). Selective intellectual deficits in children with temporal lobe or centrencephalic epilepsy. Neuropsychologia, 7, 287–300.CrossRefGoogle Scholar
  47. wellbeing. British Medical Journal, 285,425–427. Fisher, R. S. (1993). Emerging antiepileptic drugs. Neurology, 43(Suppl. 5), 5 12-S20.Google Scholar
  48. Fowler, P. C., Richards, H. C., Berent, S., and Boll, T. J. (1987). Epilepsy, neuropsychological deficits, and EEG lateralization. Archives of Clinical Neuropsychology, 2, 81–92.Google Scholar
  49. Fox, J. T. (1924). Response of epileptic children to mental and educational tests. British Journal of Medical Psychology, 4, 235–248.CrossRefGoogle Scholar
  50. Freeman, J. M., Vining, E. P. G., and Pillas, D. J. (1990). Seizures and epilepsy in childhood: A guide for parents. Baltimore: Johns Hopkins University Press.Google Scholar
  51. Geschwind, N. (1984). Dostoievsky’s epilepsy. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 325–334 ). Washington, DC: American Psychiatric Press.Google Scholar
  52. Gillham, R. A., Blacklaw, J., McKee, P. J. W., and Brodie, M. J. (1993). Effect of vigabatrin on sedation and cognition function in patients with refractory epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 1271–1275.Google Scholar
  53. Giordani, B., Berent, S., Sackellares, J. C., Rourke, D., Seidenberg, M., O’Leary, D. S., Dreifuss, F. E., and Boll, T. J. (1985). Intelligence test performance of patients with partial and generalized seizures. Epilepsia,26(1), 37–42.Google Scholar
  54. Glowinski, H. (1973). Cognitive deficits in temporal lobe epilepsy. The Journal ofNervous andMentalDisorders, 157, 129–137.CrossRefGoogle Scholar
  55. Goode, D. J., Penry, J. J., and Dreifuss, F. E. (1970). Effects of paroxysmal spike wave on continuous visuo-motor performance. Epilepsia, 11, 241–254.PubMedCrossRefGoogle Scholar
  56. Gram, L. (1989). Potential antiepileptic drugs: Lamotrigine. In R. Levy, F. E. Dreifuss, R. Mattson, B. S. Dreifuss, and J. K. Penry (Eds.), Antiepileptic drugs ( 3rd ed., pp. 947–953 ). New York: Raven Press.Google Scholar
  57. Grant, S. M., and Heel, R. C. (1991). Vigabatrin. A review of its pharmodynamics and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drug, 41, 889–926.CrossRefGoogle Scholar
  58. Graves, N. M., and Leppick, I. E. (1991). Antiepileptic medications in development. DICP Annals of Pharmacotherapy, 25, 978–986.Google Scholar
  59. Graves, N. M., and Leppick, I. E. (1993). Advances in pharmacotherapy: Recent developments in the treatment of epilepsy. Journal of Clinical Pharmacy and Therapeutics, 18, 227–242.PubMedCrossRefGoogle Scholar
  60. Grinker, R. R. (1929). The proper use of phenobarbital in the treatment of the epilepsies. Journal of the American Medical Association, 93, 1218–1219.CrossRefGoogle Scholar
  61. Guey, J., Charles, C., Coquery, C., Roger, J., and Soulayrol, R. (1967). Study of psychological effects of ethosuximide (Zaraontin) on 25 children suffering from petit mal epilepsy. Epilepsia, 8, 129–141.Google Scholar
  62. Guldvog, B., LOyning, Y., Hauglie-Hanssen, E., Flood, S., and Bjornaes, H. (1991). Surgical versus medical treatment for epilepsy. I. Outcome related to survival, seizures, and neurologic deficit. Epilepsia, 32 (3), 375–388.PubMedCrossRefGoogle Scholar
  63. Hauser, W. A. (1994). The prevalence and incidence of convulsive disorders in children. Epilepsia, 35(Suppl. 2), sl-s6.Google Scholar
  64. Haynes, S. D., and Bennett, T. L. (1991). Cognitive impairment in adults with complex partial seizures. International Journal of Clinical Neuropsychology, 12, 74–81.Google Scholar
  65. Hendricks, M. (1995, April). High fat and seizure free. Johns Hopkins Magazine, 14–20.Google Scholar
  66. Hermann, B. P., and Whitman, S. (1986). Psychopathology in epilepsy: A multi-etiological model. In S. Whitman and B. P. Hermann (Eds.), Psychopathology in epilepsy: Social dimensions (pp. 5–37 ). London: Oxford University Press.Google Scholar
  67. Hermann, B. P., Wyler, A. R., and Richey, E. T. (1988). Wisconsin Card Sorting Test performance in patients with complex partial seizures of temporal lobe origin. Journal of Clinical and Experimental Neuropsychology, 10 (4), 467–476.PubMedCrossRefGoogle Scholar
  68. Herranz, J. L., Arteaga, R., Farr, I. N., Valdizan, E., Beaumont, D., and Armijo, J. A. (1991). Dose-response study of vigabatrin in children with refractory epilepsy. Journal of Child Neurology, 6(Suppl.), 2S25–2S51.Google Scholar
  69. Himmelhock, J. M. (1984). Major mood disorders related to epileptic changes. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 271–294 ). Washington,DC: American Psychiatric Press.Google Scholar
  70. Holdsworth, L., and Whitmore, K. (1974). A study of children with epilepsy attending ordinary schools, I: Their seizure patterns, progress, and behavior in school. Developmental Medicine and Child Neurology, 16, 746–758.PubMedCrossRefGoogle Scholar
  71. Hutt, S. J., Jackson, R. M., Belsham, A. B., and Higgins, G. (1968). Perceptual-motor behavior in relation to blood phenobarbitone level. Developmental Medicine and Child Neurology, 10, 626–632.Google Scholar
  72. Idestrom, C. M., Schelling, D., Carlquist, V., and Sjoquist, F. (1972). Behavioral and psychophysiological studies: Acute effects of diphenylhydantoin in relation to plasma levels. Psychological Medicine, 2, 111–120.PubMedCrossRefGoogle Scholar
  73. Jarvis, P. E., and Barth, J. T. (1984). Halstead-Reitan Test Battery: An interpretative guide. Odessa, FL: Psychological Assessment Resources.Google Scholar
  74. Kalviainen, R., Keranen, T., and Riekkinen, P. J. (1993). Place of newer antiepileptic drugs in the treatment of epilepsy. Drugs,46(6), 1009–1024.Google Scholar
  75. Keating, L. E. (1960). A review of the literature on the relationship of epilepsy and intelligence in school children. Journal of Mental Science, 106, 1042–1059.PubMedGoogle Scholar
  76. Keith, H. M., Ewert, J. C., Green, M. W., and Gage, R. P. (1955). Mental status of children with convulsive disorders. Neurology, 5, 419–425.PubMedCrossRefGoogle Scholar
  77. Kinsman, S. L., Vining, E. P. G., Quaskey, S. A., Mellits, D., and Freeman, J. M. (1992). Efficacy of the ketogenic diet for intractable seizure disorders: Review of 58 cases. Epilepsia, 33(6), 1132–1136.Google Scholar
  78. Lansdell, H., and Mirsky, A. F. (1964). Attention in focal and centrencephalic epilepsy. Experimental Neurology, 9, 463–469.PubMedCrossRefGoogle Scholar
  79. Lantz, D., and Sterman, M. B. (1992). Neuropsychological prediction and outcome measures in relation to EEG feedback training for the treatment of epilepsy. In T. L. Bennett (Ed.), The neuropsychology of epilepsy (pp. 213–222 ). New York: Plenum Press.Google Scholar
  80. Lavadas, E., Umitta, C., and Provinciali, L. (1979). Hemisphere dependent cognitive performances in epileptic patients. Epilepsia, 20, 493–502.CrossRefGoogle Scholar
  81. Lechtenberg, R. (1984). Epilepsy and the family. Cambridge, MA: Harvard University Press.Google Scholar
  82. Lennox, W. G. (1942). Brain injury, drugs, and environment as causes of mental decay in epileptics. American Journal of Psychiatry, 99, 174–180.Google Scholar
  83. Lennox, W. G., and Lennox, M. A. (1960). Epilepsy and related disorders. Boston: Little, Brown.Google Scholar
  84. Livingston, J. H., Beaumont, D., Arzimanoglou, A., and Aicardi, J. (1989). Vigabatrin in the treatment of epilepsy in children. British Journal of Clinical Pharmacology, 27(Suppl. 1 ), 109S - 112S.Google Scholar
  85. Loiseau, P., Signoret, J. L., and Strube, E. (1984). Attention problems in adult epileptic patients. Acta Neurologica Scandinavia, 69 (Suppl. 99), 31–34.CrossRefGoogle Scholar
  86. Loiseau, P., Strube, E., Brouslet, D., Battellochi, S., Gomeni, C., and Morselli, P. L. (1980). Evaluation of memory function in a population of epileptic patients and matched controls.Acta Neurologica Scandinavia, 62 (Suppl. 80), 58–61.CrossRefGoogle Scholar
  87. Long, C. G., and Moore, J. T. (1979). Parental expectations for their epileptic children. Journal of Child Psychology and Psychiatry, 20, 313–324.CrossRefGoogle Scholar
  88. McGowan, M. E. L., Neville, B. G. R., and Reynolds, E. H. (1983). Comparative monotherapy trial in children with epilepsy. British Journal of Clinical Practice, 27 (Symp. Suppl.), 115–118.Google Scholar
  89. McGuckin, H. M. (1980). Changing the world view of those with epilepsy. In R. Canger, F. Angeleri, and J. K. Penry (Eds.), Advances in epileptology: Eleventh epilepsy international symposium (pp. 205–208 ). New York: Raven Press.Google Scholar
  90. McGuire, A. M., Duncan, J. S., and Trimble, M. R. (1992). Effects of vigabatrin on cognitive function and mood, when used as add-on therapy in patients with intractable epilepsy. Epilepsia, 33, 128–134.Google Scholar
  91. MacLeod, C. M., Dekaban, A., and Hunt, E. (1978). Memory impairment in epileptic patients: Selective effects of phenobarbital concentration. Science, 202, 1102–1104.PubMedCrossRefGoogle Scholar
  92. Masui, K., Niwa, S., Anzai, N., Kameyama, T., Saitoh, O., and Rymar, K. (1984). Verbal memory disturbances in left temporal lobe epileptics. Cortex, 20, 361–368.PubMedGoogle Scholar
  93. Matthews, C. G., and Klove, H. (1967). Differential psychological performances in motor, psychomotor, and mixed seizure classification of known and unknown etiology. Epilepsia, 8, 117–128.PubMedCrossRefGoogle Scholar
  94. Mayeux, R., Brandt, J., Rosen, J., and Benson, F. (1980). Interictal memory and language impairment in temporal lobe epilepsy. Neurology, 30, 120–125.Google Scholar
  95. Meador, K. J., Loring, D. W., Huh, K., Gallagher, B. B., and King, D. W. (1990). Comparative cognitive effects of anticonvulsants. Neurology, 40, 391–394.PubMedCrossRefGoogle Scholar
  96. Milner, B. (1975). Hemispheric specialization: Scope and limits. In B. Milner (Ed.), Hemispheric specialization and interaction (pp. 75–89 ). Cambridge, MA: MIT Press.Google Scholar
  97. Mirsky, A. F., Primoc, D. W., Ajmone-Marsan, C. A., Rosvold, H. E., and Stevens, J. R. (1960). A comparison of the psychological test performance of patients with focal and non-focal epilepsy. Experimental Neurology, 2, 75–89.PubMedCrossRefGoogle Scholar
  98. Mirsky, A. F., and Van Buren, J. M. (1965). On the nature of the “absence” in centrencephalic epilepsy: A study of some behavioral, electroencephalographic, and autonomic factors. Electroencephalography and Clinical Neurophysiology, 18, 334–348.PubMedCrossRefGoogle Scholar
  99. Morgan, A., and Groh, C. (1980). Changes in visual perception in children with epilepsy. In B. Kulig, H. Meinardi, and G. Stores (Eds.), Epilepsy and behavior `79. Lisse: Swets and Zeitlinger.Google Scholar
  100. Mumford, J. P., Beaumont, D., and Gisselbrecht, D. (1990). Cognitive function, mood, and behaviour in vigabatrin treated patients. Acta Neurologica Scandinavica, 82 (Suppl. 133), 15.Google Scholar
  101. National Institutes of Health. (1990). Consensus development conference on surgery for epilepsy (NIH Publication No. HE20.3615/2:90–1). Washington, DC: U.S. Department of Health and Human Services.Google Scholar
  102. Nellhaus, G. (1971). The ketogenic diet reconsidered (abstract). Neurology, 21, 424.Google Scholar
  103. Novelly, R. A., Augustine, E. A., Mattson, R. H., Glaser, G. H., Williamson, P. D., Spencer, D. D., and Spencer, S. S. (1984). Selective memory improvement and impairment in temporal lobectomy for epilepsy. Annals of Neurology, 15, 64–67.PubMedCrossRefGoogle Scholar
  104. O’Leary, D. S., Lovell, M. R., Sackellares, J. C., Berent, S., Giordani, B., Seidenberg, M., and Boll, J. T. (1983). Effects of age of onset of partial and generalized seizures on neuro-psychological performance in children. Journal of Nervous and Mental Disease,777(10), 624–629.Google Scholar
  105. Painter, M. J., and Gaus, L. M. (1993). Phenobarbital in seizure disorders. In E. Wyllie (Ed.), The treatment of epilepsy: Principles and practices (pp. 900–908 ). Philadelphia: Lea and Febiger.Google Scholar
  106. Pellock, J. M. (1994). The use of new anticonvulsant drugs in children. In M. R. Trimble (Ed.), New anticonvulsants: Advances in the treatment of epilepsy. (pp. 127–143 ). New York: Wiley.Google Scholar
  107. Post, R. M. (1983). Behavioral effects of kindling. In M. Parsonage (Ed.), Advances in epileptology: XIVth international symposium (pp. 173–180 ). New York: Raven Press.Google Scholar
  108. Quadfasel, A. F., and Pruyser, P. W. (1955). Cognitive deficits in patients with psychomotor epilepsy. Epilepsia, 4, 80–90.PubMedCrossRefGoogle Scholar
  109. Ramsay, R. E., and Slater, J. D. (1993). Antiepileptic drugs in clinical development. In J. A. French, M. A. Dichter, and I. E. Leppick (Eds.), New antiepileptic drug development: Pre-clinical and clinical aspects (Epilepsy research suppl. 10, pp. 45–67 ). Amsterdam: Elsevier.Google Scholar
  110. Reitan, R. M. (1974). Psychological testing of epileptic patients. In O. Magnus and L. de Hass (Eds.), The handbook of clinical neurology: Vol. 15. The epilepsies (pp. 559–575 ). Amsterdam: Elsevier.Google Scholar
  111. Reitan, R. M., and Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation (2nd ed.) Tucson, AZ: Neuropsychology Press.Google Scholar
  112. Reynolds, E. H. (1983). Mental effects of antiepileptic medication: A review. Epilepsia, 24 (Suppl. 2), 85–96.CrossRefGoogle Scholar
  113. Reynolds, E. H. (1985). Antiepileptic drugs and psychopathology. In M. R. Trimble (Ed.), The psychopharmacology of epilepsy (pp. 49–63 ). New York: Wiley.Google Scholar
  114. Reynolds, E. H., Ring, H. A., Fan, I. N., Heller, A. J., and Elwes, R. D. (1991). Open, double-blind, and long-term study of vigabatrin in chronic epilepsy. Epilepsia, 32 (4), 530–538.PubMedCrossRefGoogle Scholar
  115. Reynolds, E. H., and Travers, R. D. (1974). Serum anticonvulsant concentrations in epileptic patients with mental symptoms. British Journal of Psychiatry, 124, 440–445.Google Scholar
  116. Reynolds, E. H., and Trimble, M. R. (1985). Adverse neuropsychi- atrie effects of anticonvulsant drugs. Drugs, 29, 570–581.PubMedCrossRefGoogle Scholar
  117. Richens, A., and Yuen, A. W. C. (1991). Overview of the clinical efficacy of lamotrigine. Epilepsia, 32(Suppl. 2 ), S13 - S16.Google Scholar
  118. Ring, H. A., Heller, A. J., Fan, I. N., and Reynolds, E. H. (1990). Vigabatrin: Rational treatment for chronic epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry, 53 (12), 1051–1055.Google Scholar
  119. Rodin, E. (1984). Epileptic and pseudoepileptic seizures: Differential diagnostic considerations. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 179–195 ). Washington, DC: American Psychiatric Press.Google Scholar
  120. Roger, J., Grangeon, H., Guey, J., and Lob, H. (1968). Psychiatric and psychological effects of ethosuximide treatment in epileptics. Encephale, 57, 407–438.PubMedGoogle Scholar
  121. Rutter, M., Graham, P., and Yule, W. (1970). A neuropsychological study in childhood. Clinics in Developmental Medicine, 35/36. London: S. I. M. P. and Heinemann.Google Scholar
  122. Saletu, B., Grunberger, J., and Linzmayer, L. (1986). Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. International Journal of Clinical Pharmacology and Toxicology, 24, 362–373.Google Scholar
  123. Scarpa, P., and Carassini, B. (1982). Partial epilepsy in childhood: Clinical and EEG study in 261 cases. Epilepsia, 23, 333–341.PubMedCrossRefGoogle Scholar
  124. Schain, R. J., Ward, J. W., and Guthrie, D. (1977). Carbamazepine as an anticonvulsant in children. Neurology, 27, 476–480.PubMedCrossRefGoogle Scholar
  125. Schlumberger, E., Chavez, F., Palacios, L., Rey, E., Pajot, N., and Dulac, O. (1994). Lamotrigine in treatment of 120 children with epilepsy. Epilepsia, 35 (2), 359–367.PubMedCrossRefGoogle Scholar
  126. Schmidt, B. (1989). Potential antiepileptic drugs. I. Gabapentin. In R. Levy, R. Mattson, B. Meldrum, J. K. Penry, and F. E. Dreifuss (Eds.), Antiepileptic drugs ( 3rd ed., pp. 925–935 ). New York: Raven Press.Google Scholar
  127. Schwartz, M. L., and Dennerll, R. D. (1970). Neuropsychological assessment of children with and without questionable epileptogenic dysfunction. Perceptual and Motor Skills, 30, 111–121.PubMedCrossRefGoogle Scholar
  128. Schwartz, R. H., Boyes, S., and Aynsley-Green, A. (1989). Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Developmental Medicine and Child Neurology, 31, 152–160.PubMedCrossRefGoogle Scholar
  129. Schwartz, R. H., Eaton, J., Bower, B. D., and Aynsley-Green, A. (1989). Ketogenic diets in the treatment of epilepsy: Short-term clinical effects. Developmental Medicine and Child Neurology, 31, 145–151.PubMedCrossRefGoogle Scholar
  130. Scott, D., Moffett, A., Matthews, A., and Ettlinger, G. (1967). Effects of epileptic discharges on learning and memory in patients. Epilepsia, 8, 188–194.PubMedCrossRefGoogle Scholar
  131. Shorvon, S. D., and Reynolds, E. H. (1979). Reduction of polypharmacy for epilepsy. British Medical Journal, 2, 1023–1025. Sillanpää, M. (1993). Carbamazepine. In E. Wyllie (Ed.), The treatment of epilepsy: Principles and practices (pp. 867–886 ). Philadelphia: Lea and Febiger.Google Scholar
  132. Sivenius, J., Kalviainen, R., Ylinen, A., and Riekkinen, R. (1991). Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia, 32, 539–542.PubMedCrossRefGoogle Scholar
  133. Somerfield-Ziskind, E., and Ziskind, E. (1940). Effect of phenobarbital on the mentality of epileptic patients. Archives of Neurology and Psychiatry, 43, 70–79.CrossRefGoogle Scholar
  134. Sterman, M. B. (1993). Sensorimotor EEG feedback training in the study and treatment of epilepsy. In D. I. Mostofsky and Y. LOyning (Eds.), The neurobehavioral treatment of epilepsy (pp. 1–18 ). Hillsdale, NJ: Erlbaum.Google Scholar
  135. Sterman, M. B., and Bloomfield, S. (1987). Limbic neuronal discharge correlates of sensorimotor EEG feedback training in presurgical patients with intractable epilepsy. In D. I. Mostofsky and Y. LOyning (Eds.), The neurobehavioral treatment of epilepsy (pp. 1–18 ). Hillsdale, NJ: Erlbaum.Google Scholar
  136. Sterman, M. B., and Friar, L. R. (1972). Suppression of seizures in an epileptic following sensorimotor EEG feedback train-ing. Electroencephalography and Clinical Neurophysiology, 33, 89–95.Google Scholar
  137. Stores, G. (1973). Studies of attention and seizure disorders. Developmental Medicine and Child Neurology, 15, 376–382.PubMedCrossRefGoogle Scholar
  138. Stores, G. (1981). Problems of learning and behavior in children with epilepsy. In E. H. Reynolds and M. R. Trimble (Eds.), Epilepsy and psychiatry (pp. 33–48 ). Edinburgh: Churchill Livingstone.Google Scholar
  139. Tartara, A., Manni, R., Galimberti, C. A., Mumford, J. P., Iudice, A. S., and Perucca, E., (1989). Vigabatrin in the treatment of epilepsy: A long-term follow-up study. Journal of Neurology, Neurosurgery, and Psychiatry, 52, 467–471.Google Scholar
  140. Tarter, R. E. (1972). Intellectual and adaptive functioning in epilepsy: A review of 50 years of research. Diseases of the Nervous System, 33, 763–770.PubMedGoogle Scholar
  141. Thompson, P. J., Huppert, F. A., and Trimble, M. R. (1981). Phenytoin and cognitive function: Effects on normal volunteers and implication for epilepsy. British Journal of Clinical Psychology, 20, 155–162.PubMedCrossRefGoogle Scholar
  142. Thompson, P. J., and Trimble, M. R. (1982). Anticonvulsant drugs and cognitive functions. Epilepsia, 23, 531–544.PubMedCrossRefGoogle Scholar
  143. Tizard, J., Rutter, M., and Whitmore, K. (1969). Education, health,and behavior. London: Longsmans.Google Scholar
  144. Trimble, M. (1981). Anticonvulsant drugs, behavior, and cognitive abilities. Current Developments in Psychopharmacology 6, 65–91.PubMedCrossRefGoogle Scholar
  145. Trimble, M. R. (Ed.). (1994). New anticonvulsants: Advances in the treatment of epilepsy. New York: Wiley.Google Scholar
  146. Trimble, M. R., and Corbett, J. A. (1980). Behavioral and cognitive disturbances in epileptic children. Irish Medical Journal, 73, 21–28.Google Scholar
  147. Trimble, M. R., and Reynolds, E. H. (1976). Anticonvulsant drugs and mental symptoms. Psychological Medicine, 6, 169–178.PubMedCrossRefGoogle Scholar
  148. Trimble, M. R., and Thompson, P. J. (1981). Memory, anticonvulsant drugs, and seizures. Acta Neurologica Scandinavica, 89, 31–41.Google Scholar
  149. Trimble, M. R., and Thompson, P. J. (1984). Sodium valproate and cognitive function. Epilepsia, 25 (Suppl. 1), 560–564.CrossRefGoogle Scholar
  150. Trimble, M. R., and Thompson, P. J. (1986). Neuropsychologi-cal aspects of epilepsy. In I. Grant and K. M. Adams(Eds.), Neuropsychological assessment of neuropsychiatric disorders (pp. 321–346 ). London: Oxford University Press.Google Scholar
  151. Turner, W. A. (1907). Epilepsy. London: Macmillan and Co.Google Scholar
  152. Tymchuk, A. J. (1974). Comparison of Bander error and time scores for groups of epileptic, retarded, and behavior-problem children. Perceptual and Motor Skills, 38, 71–74.PubMedCrossRefGoogle Scholar
  153. Vajda, F. J. E. (1992). New anticonvulsants. Current Opinions in Neurology and Neurosurgery, 5, 519–525.Google Scholar
  154. Wagner, M. L. (1994). Felbamate: A new antiepileptic drug. Amer- ican Journal of Hospital Pharmacy, 51(13), 1657–1666.Google Scholar
  155. Walker, A. E., and Blumer, D. (1984). Behavioral effects of temporal lobectomy for temporal lobe epilepsy. In D. Blumer (Ed.), Psychiatric aspects of epilepsy (pp. 295–323). Washington, DC: American Psychiatric Press.Google Scholar
  156. Wallace, S. J. (1990). Add-on open trial of lamotrigine on resistant childhood seizures. Eighteenth ICNA meeting, Tokyo, p. 734.Google Scholar
  157. Waxman, S. A., and Geschwind, N. (1984). Hypergraphia in temporal lobe epilepsy. Neurology, 30, 314–317.Google Scholar
  158. Wilensky, A. J., Temkin, N. R., Ojeman, L. M., Rischer, B., and Holubkov, A. (1992). Gabapentin and carbamazepine as monotherapy and combined: A pilot study (Abstract). Epilepsia, 33, 77.Google Scholar
  159. Wilkus, R. J., and Dodrill, C. B. (1976). Neuropsychological correlates of the EEG in epileptics. I. Topographic distribution and average rate of epileptiform activity. Epilepsia, 17, 89–100.PubMedCrossRefGoogle Scholar
  160. Wilson, A., Petty, R., Perry, A., and Rose, R. C. (1983). Paroxysmal language disturbance in an epileptic treated with clobazan. Neurology, 33, 652–654.PubMedCrossRefGoogle Scholar
  161. Wolf, S. M., and Forsythe, A. (1978). Behavior disturbance, phe-nobarbital, and febrile seizures. Pediatrics, 61, 728–731. Wyllie, E. (Ed.). (1993). The treatment of epilepsy: Principles and practices. Philadelphia: Lea and Febiger.Google Scholar
  162. Wyrwicka, W., and Sterman, M. B. (1968). Instrumental conditioning of sensorimotor cortex EEG spindles in the waking cat. Physiology and Behavior, 3, 703–707.CrossRefGoogle Scholar
  163. Zimmerman, E T., Burgemeister, B. B., and Putnam, T. J. (1951). Intellectual and emotional makeup of the epileptic. Archives of Neurology and Psychiatry, 65, 545–556.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Thomas L. Bennett
    • 1
  • Maile R. Ho
    • 1
  1. 1.Department of PsychologyColorado State UniversityFt. CollinsUSA

Personalised recommendations